Lilly Eli Co (LLY)

12:30 PM

Eli Lilly's pre-launch inventories capitalized were $952.3 mln as of September 30 - MarketScreener

12:30 PM

12:12 PM

Eli Lilly Stock Rises -- Blowout Earnings Smash Forecasts, Lifts 2025 Outlook - Yahoo Finance

12:12 PM

12:07 PM

Obesity, diabetes treatments fuel Eli Lilly growth and spark bidding war - JG-TC.com

12:07 PM

11:46 AM

Eli Lilly says weight-loss pill a candidate for speedy approval under new US program - Yahoo! Finance Canada

11:46 AM

11:33 AM

Stock Movers: Meta Falls, Chipotle Plunges, Eli Lilly Jumps - Bloomberg.com

11:33 AM

11:31 AM

Global markets live: Mastercard, Nvidia, Alphabet, Eli Lilly, Shell… - MarketScreener

11:31 AM

11:23 AM

ELI LILLY & Co SEC 10-Q Report - TradingView

11:23 AM

11:22 AM

Lilly hikes revenue forecasts on booming obesity drug sales - BioPharma Dive

11:22 AM

11:08 AM

Eli Lilly Planning $1.2 Billion Investment in Puerto Rico Manufacturing Site - Pharmaceutical Commerce

11:08 AM

11:01 AM

Eli Lilly Smashes Views On Back Of Mounjaro, Zepbound - Investor's Business Daily

11:01 AM

10:54 AM

Eli Lilly exceeds expectations and raises its targets thanks to success of Mounjaro and Zepbound - MarketScreener

10:54 AM

10:46 AM

Eli Lilly Boosts Its Outlook on High Demand for Popular Weight-Loss Drugs - Investopedia

10:46 AM

10:42 AM

Eli Lilly (LLY) Stock: Q3 Earnings Soar Past Estimates on Weight Loss Drug Sales - parameter.io

10:42 AM

10:33 AM

Eli Lilly Stock (LLY) Soars as Pharma Giant Raises 2025 Revenue Guidance and Commits $1.2B to Puerto Rico Expansion - Zoom Bangla News

10:33 AM

10:07 AM

Eli Lilly raises full-year forecast, as weight-loss drugs demand drives third-quarter beat - Yahoo Finance

10:07 AM

10:05 AM

Mounjaro And Zepbound Power Eli Lilly's 54% Revenue Jump In Q3, Hikes 2025 Forecast - Benzinga

10:05 AM

10:05 AM

Eli Lilly raises forecasts on surging international demand for weight-loss drugs - Reuters

10:05 AM

09:55 AM

Eli Lilly Q3 earnings and revenue top estimates, boosted by weight loss drug demand - Proactive Investors

09:55 AM

09:43 AM

TD Cowen Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $960 - 富途牛牛

09:43 AM

09:42 AM

Eli Lilly (LLY) Boosts Profit Forecast Amid Strong Demand for Di - GuruFocus

09:42 AM

09:33 AM

Lilly Ups Guidance on Weight Loss, Obesity Drugs’ Strength - Bloomberg.com

09:33 AM

09:31 AM

Eli Lilly (LLY) Stock Soars on Weight-Loss Drug Boom – Can It Hit $1,000? - ts2.tech

09:31 AM

09:29 AM

LLY Earnings: Eli Lilly Stock Soars Thanks to Massive Year-Over-Year Growth - TipRanks

09:29 AM

09:25 AM

Eli Lilly Blows Away Q3 Earnings Expectations - 24/7 Wall St.

09:25 AM

09:25 AM

Novo Nordisk's bid for Metsera, Eli Lilly boosts revenue outlook - Yahoo Finance

09:25 AM

09:22 AM

Eli Lilly Stock Rises on Earnings and Boost to Guidance - Barron's

09:22 AM

09:20 AM

Eli Lilly and Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener

09:20 AM

09:15 AM

Eli Lilly and Company (LLY) Stock: Plunge After Q3 2025 Revenue Beat and Upgraded Outlook - CoinCentral

09:15 AM

09:12 AM

LLY Stock Update: Eli Lilly Shares Hold Firm Amid Strong Earnings - International Business Times

09:12 AM

09:09 AM

Eli Lilly Tops Earnings Forecasts and Raises Outlook as Zepbound and Mounjaro Sales Surge - Yahoo Finance

09:09 AM

09:07 AM

Eli Lilly’s weight loss and diabetes drug tops Keytruda as world’s best-selling medicine - statnews.com

09:07 AM

09:07 AM

Eli Lilly (LLY) Q3 Earnings and Revenues Surpass Estimates - sharewise.com

09:07 AM

09:06 AM

Zepbound Topples Sales King Keytruda as Lilly Reports 54% YoY Revenue Rise for Q3 - BioSpace

09:06 AM

08:40 AM

Eli Lilly stock soars on strong Q3 earnings - Latest news from Azerbaijan

08:40 AM

08:32 AM

Eli Lilly (LLY) Raises Full-Year Outlook Amid Strong Earnings - GuruFocus

08:32 AM

08:23 AM

Stocks making the biggest moves premarket: Alphabet, Microsoft, Meta Platforms, Eli Lilly, Merck & more - CNBC

08:23 AM

08:12 AM

Eli Lilly (LLY) Surges After Beating Q3 Expectations and Raising 2025 Outlook - GuruFocus

08:12 AM

08:09 AM

Eli Lilly’s stock jumps as Zepbound sales nearly triple at lower prices - MarketWatch

08:09 AM

08:08 AM

Eli Lilly and Company (NYSE:LLY) Releases FY 2025 Earnings Guidance - MarketBeat

08:08 AM

08:01 AM

Lilly Continues Manufacturing Push With $1.2B Puerto Rico Facility for GLP-1 Pill - BioSpace

08:01 AM

07:59 AM

Eli Lilly’s Weight-Loss Drugs Power Record Revenue Growth - Finimize

07:59 AM

07:57 AM

Eli Lilly ups full-year profit forecast amid soaring demand for weight-loss drug Zepbound, stock jumps 7% - Mint

07:57 AM

07:57 AM

Mounjaro Powers Eli Lilly to Bumper Quarter of Earnings - The Wall Street Journal

07:57 AM

07:46 AM

Lilly earnings soar on growth of Mounjaro, Zepbound - Indianapolis Business Journal

07:46 AM

07:44 AM

Eli Lilly's (LLY) Q3 Revenue Surpasses Expectations - GuruFocus

07:44 AM

07:44 AM

Eli Lilly (LLY) Increases Revenue and EPS Guidance for FY25 - GuruFocus

07:44 AM

07:37 AM

Eli Lilly raises annual revenue guidance amid strong weight-loss drug demand - Investing.com

07:37 AM

07:35 AM

Lilly: Q3 Earnings Snapshot - San Francisco Chronicle

07:35 AM

07:31 AM

Alphabet, Eli Lilly and Estee Lauder rise premarket; Meta, Microsoft fall - Investing.com

07:31 AM

07:30 AM

Eli Lilly ramps up orforglipron production with $1.2bn Puerto Rico site expansion - Pharmaceutical Technology

07:30 AM

07:26 AM

Eli Lilly Delivers Strong Q3 Performance, Raises Earnings Outlook - Tokenist

07:26 AM

07:22 AM

Eli Lilly (LLY) Surpasses Q3 Expectations with Strong Earnings - GuruFocus

07:22 AM

07:21 AM

Eli Lilly raises full-year forecast, sees sustained demand for weight-loss drugs - MarketScreener

07:21 AM

07:21 AM

New Walmart Partnership to Let Patients Buy Eli Lilly's Zepbound Without Insurance Hassles - International Business Times

07:21 AM

07:20 AM

Eli Lilly Stock on Fire: GLP-1 Bonanza, Big Earnings & AI Pivot Drive Rally - ts2.tech

07:20 AM

07:20 AM

Eli Lilly (NYSE:LLY) Delivers Strong Q3 Numbers, Stock Soars - The Globe and Mail

07:20 AM

07:20 AM

Eli Lilly Raises Outlook on Soaring GLP-1 Demand - The Wall Street Journal

07:20 AM

07:13 AM

Eli Lilly raises forecasts on surging demand for weight-loss drugs - Yahoo! Finance Canada

07:13 AM

07:11 AM

Eli Lilly in charts: Obesity and diabetes portfolio drives growth in Q3 with Mounjaro +109% and Zepbound +185% Y/Y - Seeking Alpha

07:11 AM

07:09 AM

(LLY) Eli Lilly Expects 2025 Revenue Range $63.0B to $63.5B, vs. FactSet Est of $61.74B - MarketScreener

07:09 AM

07:08 AM

Earnings Flash (LLY) Eli Lilly and Company Reports Q3 Revenue $17.60B, vs. FactSet Est of $16.05B - MarketScreener

07:08 AM

07:07 AM

Eli Lilly stock pops on raised full-year outlook (LLY:NYSE) - Seeking Alpha

07:07 AM

07:06 AM

Eli Lilly and : Q3 2025 Lilly Presentation - MarketScreener

07:06 AM

07:04 AM

Eli Lilly rises after earnings, sales blow past Wall Street’s expectations - Sherwood News

07:04 AM

06:58 AM

Eli Lilly raises full-year forecast, sees sustained demand for weight-loss drugs By Reuters - Investing.com

06:58 AM